MedTrace Logo

Investigation of the Tolerability of Two Facial Cleansing Routines for Mild to Moderate Acne

NCT05446402 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 29

Last updated 2024-04-11

No results posted yet for this study

Summary

The objective of this study is to compare tolerability of two similar commercially available over the counter acne regimens (Geologie and Proactiv) in individuals with mild to moderate acne vulgaris over a 12-week daily treatment course.

Conditions

Interventions

COMBINATION_PRODUCT

Geologie Acne Regimen - one side of face

Geologie is an over-the-counter cosmetic acne regimen with three products. The regimen also has three "levels" over the course of three months, in which the nighttime lotion is switched to a stronger formula each month. The Geologie Clear System regimen for acne prone skin includes: 1. Clarifying Gel Cleanser - SA Formula (2% Salicylic Acid) 2. Brightening Day Cream - SPF 15 (5% Azelaic Acid, 2% Hyaluronic Acid, 1%Niacinamide) 3. Repairing Night Cream - 1. Level 1 (0.05% Retinol, 3% Niacinamide, 2% Hyaluronic Acid) 2. Level 2 (0.2% Retinol, 3% Niacinamide, 2% Hyaluronic Acid) 3. Level 3 (0.3% Retinol, 3% Niacinamide, 2% Hyaluronic Acid)

COMBINATION_PRODUCT

Proactive Acne Regimen - other side of face

ProActiv is an over-the-counter cosmetic regimen with three products. The Proactiv Solution 3-Piece System regimen includes: 1. Renewing Cleanser (Active ingredient: 2.5% Benzoyl Peroxide) 2. Revitalizing Toner (Glycolic Acid) 3. Repairing Treatment (Active ingredient: 2.5% Benzoyl Peroxide)

Sponsors & Collaborators

Principal Investigators

  • Stephanie Rangel · Northwestern University

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-06-15
Primary Completion
2023-05-31
Completion
2023-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05446402 on ClinicalTrials.gov